Martha J. Demski Sells 8,000 Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) Stock

Alpha Teknova, Inc. (NASDAQ:TKNO - Get Free Report) Director Martha J. Demski sold 8,000 shares of the firm's stock in a transaction dated Friday, June 27th. The stock was sold at an average price of $5.06, for a total transaction of $40,480.00. Following the transaction, the director owned 12,000 shares of the company's stock, valued at approximately $60,720. This represents a 40.00% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Alpha Teknova Price Performance

Shares of NASDAQ TKNO traded up $0.04 during mid-day trading on Wednesday, hitting $4.97. 19,064 shares of the stock were exchanged, compared to its average volume of 385,507. Alpha Teknova, Inc. has a twelve month low of $1.15 and a twelve month high of $10.37. The stock's fifty day simple moving average is $6.00 and its two-hundred day simple moving average is $6.77. The company has a debt-to-equity ratio of 0.17, a quick ratio of 4.71 and a current ratio of 5.64. The company has a market cap of $265.60 million, a P/E ratio of -10.36 and a beta of 0.33.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported ($0.09) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.02. The firm had revenue of $9.60 million for the quarter, compared to analyst estimates of $9.41 million. Alpha Teknova had a negative net margin of 60.90% and a negative return on equity of 28.48%. As a group, analysts forecast that Alpha Teknova, Inc. will post -0.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Invesco Ltd. acquired a new stake in shares of Alpha Teknova during the fourth quarter worth $9,236,000. CenterBook Partners LP bought a new position in Alpha Teknova during the 1st quarter worth about $1,581,000. Bank of America Corp DE raised its stake in shares of Alpha Teknova by 1.8% in the 4th quarter. Bank of America Corp DE now owns 221,285 shares of the company's stock valued at $1,848,000 after purchasing an additional 3,904 shares during the period. Susquehanna International Group LLP lifted its holdings in shares of Alpha Teknova by 472.5% in the fourth quarter. Susquehanna International Group LLP now owns 209,409 shares of the company's stock valued at $1,749,000 after purchasing an additional 172,828 shares in the last quarter. Finally, Tradewinds LLC. boosted its position in shares of Alpha Teknova by 205.6% during the first quarter. Tradewinds LLC. now owns 133,088 shares of the company's stock worth $691,000 after buying an additional 89,538 shares during the period. 13.81% of the stock is owned by institutional investors and hedge funds.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.